A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tersera Investigational Site
Gilbert, Arizona, United States
- Tersera Investigational Site
Fullerton, California, United States
- Tersera Investigational Site
Gainesville, Florida, United States
- Tersera Investigational Site
Tampa, Florida, United States
- Tersera Investigational Site
Chicago, Illinois, United States
- Tersera Investigational Site
Westwood, Kansas, United States
- Tersera Investigational Site
Lexington, Kentucky, United States
- Tersera Investigational Site
Boston, Massachusetts, United States
- Tersera Investigational Site
Grand Rapids, Michigan, United States
- Tersera Investigational Site
Buffalo, New York, United States
- Tersera Investigational Site
Lake Success, New York, United States
- Tersera Investigational Site
Charlotte, North Carolina, United States
- Tersera Investigational Site
Oklahoma City, Oklahoma, United States
- Tersera Investigational Site
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Mar 2019
- Primary completion
- 13 Jan 2022
- Completion
- 13 Jan 2022
- Last update posted
- 19 Apr 2023
- Registered enrollment
- 53
- Registry id
- NCT03790111
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.